Immunotherapy: How the Immune System Conquers Cancer

Added:

The Limitations, Resistance, and Severe Toxicity of Immunotherapy

While immunotherapy has revolutionized oncology, it is not a universal cure and faces critical challenges. First, it is only effective in a minority of patients; many cancers are 'cold tumors' that do not trigger an immune response, and others quickly develop resistance. Second, unleashing the immune system can cause severe, life-threatening autoimmune reactions, such as Cytokine Release Syndrome (CRS) in CAR-T therapy or organ inflammation from checkpoint inhibitors. Finally, the astronomical cost of these treatments creates massive global inequality in cancer care. Consequently, traditional therapies like surgery, chemotherapy, and radiation remain essential, and the narrative of immunotherapy 'conquering' cancer must be tempered with these clinical and economic realities.

Basic anatomy and physiology of the human immune system, specifically the roles of T-cells, B-cells, and antigen-presenting cells (APCs).
Fundamentals of cancer biology, including how genetic mutations lead to uncontrolled cell division and tumor formation.
The concept of antigen recognition and how the immune system distinguishes between 'self' and 'non-self' or abnormal cells.
The physiological purpose of immune checkpoint pathways (such as PD-1 and CTLA-4) in preventing autoimmunity in healthy tissues.
Clinical challenges of immunotherapy, including mechanisms of tumor resistance and the management of immune-related adverse events (irAEs) like cytokine release syndrome.
The design and genetic engineering process behind CAR-T cell manufacturing, including viral vectors and gene editing technologies.
Advanced clinical applications, such as combination therapies pairing immunotherapy with chemotherapy, radiation, or targeted molecular therapies.
Personalized medicine in oncology, specifically the use of biomarkers (e.g., tumor mutational burden and PD-L1 expression) to predict patient response to immunotherapies.
104.2K views1.6Klikes15:34@TEDxOriginal Release: 2016-12-21

Immunotherapy is a revolutionary cancer treatment approach that leverages the body's immune system to recognize and destroy cancer cells, representing a paradigm shift from traditional treatments like surgery, chemotherapy, and radiation. The immune system identifies cancer cells through molecular markers on cell surfaces, but tumors often develop protective checkpoints that suppress immune responses. Modern immunotherapies, including checkpoint inhibitors (which block these off-switches), CAR T-cell therapy (which engineers patients' immune cells to target cancer), and personalized vaccines (which teach the immune system to recognize unique tumor mutations), have shown remarkable success in treating previously untreatable cancers. These advances demonstrate that cancer treatment is moving toward personalized, precision medicine tailored to each patient's specific tumor characteristics.